New insights into the cardio-renal benefits of SGLT2 inhibitors and the coordinated role of miR-30 family
Sodium-glucose co-transporter inhibitors (SGLTis) are the latest class of anti-hyperglycemic agents. In addition to inhibiting the absorption of glucose by the kidney causing glycosuria, these drugs also demonstrate cardio-renal benefits in diabetic subjects. miR-30 family, one of the most abundant...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
KeAi Communications Co., Ltd.
2024-11-01
|
| Col·lecció: | Genes and Diseases |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2352304223004579 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|